Wells score
Wells Score is a clinical prediction rule used in the diagnosis of pulmonary embolism (PE). It was developed by Dr. Philip Wells and his team in 1998. The Wells Score is a tool that helps physicians determine the likelihood of PE in a patient based on clinical signs and symptoms.
Overview[edit]
The Wells Score is a scoring system that assigns points to various clinical features and risk factors associated with PE. The total score is then used to categorize patients into different risk groups: low, moderate, or high risk. The higher the score, the greater the likelihood of PE.
Scoring System[edit]
The Wells Score includes seven criteria, each assigned a certain number of points:
- Clinical signs and symptoms of deep vein thrombosis (DVT) (3 points)
- An alternative diagnosis is less likely than PE (3 points)
- Heart rate over 100 beats per minute (1.5 points)
- Immobilization or surgery in the previous four weeks (1.5 points)
- Previous objectively diagnosed PE or DVT (1.5 points)
- Hemoptysis (1 point)
- Malignancy (1 point)
The total score can range from 0 to 12.5. A score of less than 2 indicates a low probability of PE, a score of 2 to 6 indicates a moderate probability, and a score greater than 6 indicates a high probability.
Clinical Use[edit]
The Wells Score is used in conjunction with diagnostic testing, such as D-dimer testing and computed tomography pulmonary angiography (CTPA), to diagnose PE. It helps physicians decide which patients require further testing and which can be safely discharged without further workup.
Limitations[edit]
While the Wells Score is a useful tool, it has some limitations. It is not 100% accurate and should not be used in isolation to rule in or rule out PE. It should always be used in conjunction with other diagnostic tests and clinical judgment.
See Also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian